The results of two studies found that using the drug abiraterone in combination with other hormonal therapy drugs to treat aggressive prostate cancer produced more favorable results than the first-line therapy alone. The post Combination hormonal therapy boosts survival in men with aggressive prostate cancer appeared first on Harvard Health Blog.
A novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer-specific protein has been described in a new article.
Data from the Corporal Michael J. Crescenz Veterans Affairs Medical Center in Philadelphia showed that doctors there were ordering bone scans at three times the national rate for a certain group of prostate cancer patients. It called for a coaching visit to the pitcher's mound.
(The Wistar Institute) A study led by Wistar scientists describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer-specific protein.
A new cause of treatment resistance in prostate cancer has been uncovered by investigators. Their discovery also suggests ways to improve prostate cancer therapy.
(Mayo Clinic) ROCHESTER, Minn. -- Mayo Clinic researchers have identified a new cause of treatment resistance in prostate cancer. Their discovery also suggests ways to improve prostate cancer therapy. The findings appear in Nature Medicine.
Johns Hopkins Kimmel Cancer Center scientists report they have discovered a biochemical process that gives prostate cancer cells the almost unnatural ability to change their shape, squeeze into other organs and take root in other parts of the body. Show More Summary
(American College of Physicians) Both biophosphonates and denosumab improve bone mineral density in men with nonmetastatic prostate cancer who are receiving androgen deprivation therapy. The results from a systematic review and meta-analysis are published in Annals of Internal Medicine.
Researchers have demonstrated the potential of a new PET tracer, Carbon-11 labeled sarcosine (11C-sarcosine), for imaging prostate cancer, and set the stage for its possible use in monitoring other cancers.
(Society of Nuclear Medicine) In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the University of Michigan demonstrate the potential of a new PET tracer, Carbon-11 labeled sarcosine (11C-sarcosine), for imaging prostate cancer, and set the stage for its possible use in monitoring other cancers.
(University Health Network) Prostate cancer researchers have mapped the impact of an acquired mutation that alters epigenetic identity, the make-up of DNA, in about 50 percent of patient tumor samples. The discovery also identifies a new opportunity for targeted therapy.
A research study to remove cancerous cells in the prostate using Magnetic Resonance Imaging guided technology is entering its final phase at Beaumont.
(University of Colorado Anschutz Medical Campus) Using open data from four previously conducted clinical trials, teams of international researchers designed mathematical models predicting the likelihood that a patient will discontinue docetaxel treatment due to adverse events.
Men who participated in yoga classes twice a week while being treated for prostate cancer reported less fatigue and better urinary and erectile function, compared to other men in the study who did not do yoga. The post Yoga improves treatment-related symptoms in men with prostate cancer appeared first on Harvard Health Blog.
Systematic studies on the association between men’s sexual dysfunction (low sexual desire, ejaculation disorders, erectile dysfunctions, genital ulcers, testicular disorders, prostate cancer or sexually transm...
Research into pomegranate juice and prostate cancer Some research suggests that drinking pomegranate juice may slow the progression of prostate cancer. While those findings are only preliminary, several clinical trials are underway. Learn more from Dr. Show More Summary
Prostate cancer blogs are helpful for patients and caregivers alike. We have selected the best prostate cancer blogs that provide information and support.
U.S. Rep. Phil Roe's office says he has been diagnosed with early-stage prostate cancer and will undergo treatment next month in Tennessee. Roe's website said the cancer was discovered after … Click to Continue »
Rep. Phil Roe says he has been diagnosed with early-stage prostate cancer, but that the prognosis is "excellent."